Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19

NCT04556864 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2020-09-21

No results posted yet for this study

Summary

The aim of the present work is to describe the hemodynamic effects shown in patients with ARDS secondary to SARS-CoV-2 infection

Conditions

  • Covid19
  • Hemodynamic Instability
  • ARDS, Human

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY
  • Juan Victor Lorente

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2020-12-30
Completion
2021-04-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04556864 on ClinicalTrials.gov